Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Gemcitabine 15 Cisplatin 12 Radiotherapy 11 Metformin 8 Fluorouracil 8 Capecitabine 8 Paclitaxel 7 Oxaliplatin 7 Exercise 7 Indocyanine Green 6 Docetaxel 6 Cyclophosphamide 6 Control Groups 6 Surveys and Questionnaires 5 Standard of Care 5 Nivolumab 5 Letrozole 5 Irinotecan 5 pembrolizumab 4 durvalumab 4 Zoledronic Acid 4 Vinorelbine 4 Saline Solution 4 Preoperative Exercise 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Ifosfamide 4 Gefitinib 4 Drug Therapy 4 Carboplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER_GOV × Environment × Clear all

NCT03670927 2024-11-07

ETIOSARC

Institut National de la Santé Et de la Recherche Médicale, France

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡